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ABSTRACT OF THE THESIS 
THE EFFECTS OF DYNAMIC CULTURING ENVIRONMENTS ON CELL 
POPULATIONS RELEVANT TO HEART VALVE TISSUE ENGINEERING  
by 
Catalina Martinez 
Florida International University, 2011 
Miami, Florida 
Professor Sharan Ramaswamy, Major Professor 
The design of a tissue engineered pulmonary valve (TEPV) involves cells 
source(s), scaffold, in vitro conditioning system and the functional stability 
of the TEPV in vivo. Vascular cells (pulmonary artery smooth muscle  
(SMCs) and endothelial cells (ECs)) and periodontal ligament derived 
stem cells (PDLSCs) are relevant sources for the designing of TEPVs. In 
this study, labeling of these cell populations with super paramagnetic iron 
oxide microparticles along with concomitant usage of transfection agents 
was followed by visualization using magnetic resonance, while 
Intracellular iron oxide was confirmed by prussian blue staining and 
fluorescence microscopy. Also, the potential of PDLSC as a feasible 
source for TEPVs was investigated, expressing differentiative capacity to 
both SMC and EC phenotypes by a combination of biochemical and 
mechanical stimulation. Flow conditioning in a u-shaped bioreactor 
augmented collagen production in SMC-EC (99.5% for n=3) and PDLSC 
(93.3% for n=3) seeded scaffolds after a 3-week culturing period (P<0.05). 
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1. INTRODUCTION 
There are over 25,000 infants born with congenital heart anomalies in the 
US alone (www.congenitalheartdefects.com), which usually demand either 
replacement of the pulmonary valve (PV) and/or reconstruction of the right 
ventricular outflow tract (RVOT). Available PV replacements in the market are: 
mechanical, xenograft fixed-tissue, and homograft valves. Prosthetic heart valves 
are implanted in approximately 275,000 patients yearly (1). However, current 
prosthetic heart valves have several limitations. Mechanical valves are prone to 
thrombosis; therefore life-long anticoagulant therapy is required (2). Xenograft 
fixed-tissue, commonly referred to as bioprosthetic heart valves do not require 
anticoagulants, but they have limited durability and are prone to calcification (3). 
Homograft valves are limited in availability and often experience immune 
rejection (4). Overall, none of these valve replacement strategies offer potential 
for growth, and are hence particularly limited for pediatric patients, as they will 
require multiple operations during their development.  (1,5-7).  
2. LITERATURE SEARCH 
2.1 Heart Valve Disease (HVD) – Heart Valve disease (HVD) results from 
the malfunctioning of one or more heart valves and is affected by factors such as 
immune reaction, trauma, inheritance and environmental factors (diet, smoking, 
etc.). The main job of heart valves is to open and close in a synchronized manner 
allowing blood to flow in one direction and preventing back flow. A significant 
amount of HVD is characterized by valve stenosis, causing the valve to become 
narrow, therefore affecting hemodynamics by decreasing the cross sectional 
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area for blood to flow. Similarly, improper valve closure causes regurgitation, 
creating a backflow of blood into the heart. In this study, we are specifically 
concerned with the pulmonary valve (PV), which lies between the right ventricle 
and the pulmonary artery and has three cusps responsible for blood flow from the 
heart to the lungs, as well as the exchange of oxygen and carbon dioxide. 
Malfunction of a PV demands a replacement by currently available designs. 
2.2 PV Replacements – The actual PV replacements available are 
mechanical, bioprosthetic or homograft valves. Mechanical heart valves (MHVs) 
are generally built from of titanium or pyrolytic carbon; their first designs include 
the caged ball, tilting disk and bileaflet versions (2). Bioprostheric heart valves 
(BHVs) are native valves usually derived from bovine or porcine sources, which 
undergo a fixative chemical process before implantation in the human body (6,7). 
All of these replacements are beneficial for the patient; yet they have serious 
limitations. For example, MHVs are durable, but are thrombogenic, require life-
long anticoagulants, and therefore are more prone to infection (2). BHVs do not 
require anticoagulants, but do not last as long as MHVs as they undergo 
calcification on their leaflets (3). Homograft valves on the other hand, contain 
some viable cells which would permit some tissue remodeling activity; however 
as they are allografts, the often experience immunological rejection.  
2.3 Tissue Engineered Heart Valves (TEHV) – Tissue engineering 
applies principles of engineering and life sciences toward the development of 
biological substitutes. This approach utilizes a bioabsorbable scaffolding material, 
seeded with cells and grown in vitro, to ultimately produce functional living tissue 
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which can be implanted in the body (8). The extracellular matrix (ECM) formed by 
the autologous cells provides the basic framework for the tissue and it is also 
responsible for its mechanical and structural properties. Cells organize, grow, 
proliferate and produce native ECM on the scaffold’s temporary matrix. In theory, 
due to their ability to permit somatic growth, the creation of a tissue-engineered 
structure from autologous cells can potentially offer several advantages over 
currently available treatment options (1, 4, 8). Additionally, tissue engineered 
pulmonary heart valves (TEPVs) would have fewer supply limitations in 
comparison with homografts. The Mayer group (9) found promising results, 
creating PV leaflets and sections of the main pulmonary artery. These structures 
were found to be non-thrombogenic and promote tissue remodeling. However, 
they had limited durability in the order of months (9). Sutherland et al. 
constructed TEHVs by seeding bone marrow derived stem cells (BMSC) onto 
nonwoven scaffolds that functioned in the pulmonary outflow tract of sheep for 8 
months (8). While the results from these studies are clearly encouraging, the 
current critical step for TEHV research is to identify a clinically viable autologous 
cell source, a scaffold with the suitable mechanical and biodegradable properties, 
an optimized in vitro conditioning system, and a way to track the functional 
stability of the tissue engineering implant in vivo in order to successfully move 
forward from in vitro conditioning into in vivo studies, and subsequently to clinical 
trials (10).  
2.4 Cell Sources for Tissue Engineered Pulmonary Valves – Three 
relevant cell sources pertinent in tissue engineered hear valve efforts include 
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human vascular cells (native pulmonary artery smooth muscle  (SMCs) and 
endothelial cells (ECs)) and stem cell sources. Vascular cells (SMCs and ECs) 
have shown to promote heart valve tissue formation (1, 9, 11). Therefore, these 
vascular cells need to be assessed in order to track tissue remodeling in vivo. 
Studies using bone marrow derived stem cells (BMSCs) which are readily 
accessible, have shown that after a TEPV has been implanted, the BMSCs 
exhibit some pluripotency for potential vascularization of bioengineered tissues 
(8).  Evidence of smooth muscle cell phenotype has been obtained by Sutherland 
et al. (8) by expressing vimentin, and alpha-smooth muscle actin (alpha-SMA) 
markers in his studies. However they could not detect evidence of endothelial cell 
phenotype. 
Human periodontal ligament derived stem cells (PDLSCs) on the other 
hand, are a readily available source of pluripotent stem cells that may potentially 
support the valve phenotype. They are derived from the cranial neural crest and 
recent studies by Huang et al. (12) have shown that PDLSCs are a population of 
multipotent stem cells that can be differentiated into neural and mesenchymal 
lineages. Sub-populations of PDLSCs contain 4 embryonic stem cell markers 
(Oct4, Nanog, Sox2, Klf4) and exhibit the potential to differentiate to neurogenic, 
cardiomyogenic, osteogenic and chondrogenic cell lineages (12). Therefore, 
PDLSCs have the potential to promote concomitant differentiation into the EC 
and SMC phenotypes (12-14).  
2.5 Scaffold Material for Tissue Engineered Pulmonary Valves – The 
scaffold material serves as a support structure capable of retaining cells and 
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engineered tissue formation. Scaffold materials must allow cell attachment and 
migration, enable diffusion of cell nutrient and expressed products, as well as 
possess mechanical and biological properties to provide structural support. 
TEPVs are usually constructed by seeding cells onto porous synthetic of natural 
scaffolds (5). Natural scaffolds, from decellularized valve tissue already have 
proper anatomical structure, intrinsic bioactivity and desired mechanical 
properties (5). However, their innate variability, limited supply, and potential 
immunogenic reaction are obstacles in the field.  
On the other hand, synthetic scaffolds offer the added benefit of design 
flexibility, in which their material and structural properties, as well as anatomical 
shape can be tailored to meet the functional necessities (15,16). Polyesters such 
as polyglycolic acid (PGA) and poly-l-latic acid (PLLA) are the most widely used 
scaffold materials in the field of TEPVs. These materials mixed together in a 
50:50 blend create an immunogenic scaffold capable of degrading by hydrolysis 
into naturally occurring metabolites (15,16). This scaffold has an approximate 
fiber diameter of 0.012-0.015mm and a density of 61.75 mg/ml. Its benefits 
include a high porosity factor (>97%) allowing for a high cell seeding density.  
The PGA/PLLA scaffold has already been successful demonstrating its ability to 
rapidly grow cells and form an organized 3D tissue structure (1,5). 
2.6 In Vitro Conditioning Systems – Mechanical stimulation of 
engineered tissue growth in vitro can be achieved with a bioreactor, which has 
shown to improve the physical integrity of engineered heart valves prior to 
implantation (9,16,17). The mechanical environment would potentially include a 
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physiological flow and pressure for conditioning the developing valve tissue 
construct in a sterile setting prior to in vivo implantation (17-19). Different 
bioreactors have been designed by researchers to promote tissue formation and 
valve phenotype (5,9,16-19).  Hoerstrup et al (17) developed an in vitro cell 
culture system that provided the developing valve constructs with physiological 
pressure and flow to develop adequate strength of the constructs prior to 
implantation.  In a similar manner, Sticker et al (18) conducted a study to 
compare tissue samples exposed to stretch versus normal conditions showing 
there is higher tissue production on samples treated mechanically, i.e exposed to 
cyclic flexure.  Engelmayr et al (5) showed that laminar flow combined with cyclic 
flexure in a flow-stretch-flex (FSF) bioreactor allowed for larger tissue formation 
when compared to laminar flow without cyclic flexure when seeding BMSCs in a 
non-woven scaffold material (PGA/PLLA). However, Engelmayr this study did not 
use physiological levels, as the shear stresses were very low. The effects of fluid 
shear stresses on engineered tissue growth levels (i.e. collagen) can be 
evaluated in terms of bulk protein levels, differentiation potential, mechanical 
properties, gene expression and cell signaling events.  
The device utilized in our study, is an u-shaped bioreactor capable of 
replicating physiological hemodynamic conditions during in vitro tissue 
development, while keeping laminar conditions as shown by precise steady state 
states. This is a key advantage over other bioreactor designs incapable of 
generating physiologically relevant stresses, which have been widely recognized 
as an essential aspect of engineered heart valve tissue formation (5,16). 
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2.7 Noninvasive Visualization of Functional TEPV’s – A cell-tracking 
agent is required to be safe to use, i.e., does not alter cell activity, and permits 
retention within the cell for a reasonable period to allow for visualization over 
longitudinal time points (20). One approach would be to label the cells with super 
paramagnetic iron oxide (SPIO) microparticles and visualize the resulting 
artifacts as regions of signal voids characterized using magnetic resonance 
imaging (MRI). Other cell tracking methods include labeling with green 
fluorescent protein (GFP). However, this method is harmful for the tissue, as it 
may interfere with the protein synthesis of the cells and does not provide 
sufficient resolution beyond that of subcutaneous tissue, which is needed for the 
heart valve application (21). Another cell tracking method involves gadolinium 
compounds, which create contrast through T1 images, however the main 
disadvantage of this contrast agent lies on its low sensitivity (22). On the other 
hand, SPIO microparticles have already been demonstrated to work for MRI 
investigations without harming the cell (23-26). For example, Terrovitis et al. (24) 
showed that labeling BMSCs with ferumoxides was not toxic to the cells, and the 
cells could further be visualized in collagen gels/scaffolds. Ko et al. (27) showed 
that cellular MRI methodologies could further be used to visualize an implanted 
scaffold and the cellular behavior around the scaffold in the mouse model.  
 MRI has been reported to be useful in monitoring TEPV growth and 
function in vivo  (20). MRI allows cell detection utilizing SPIO microparticles as 
the contrast agent by accelerated T2* decay, which will present as hypointense 
regions caused by the intracellular iron oxide particles (10). This visualization is 
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necessary from the beginning of the in vitro culturing period of the engineered 
construct and could in theory be progressively tracked, even after implantation (8, 
28-30).   
To understand a process where there are many unknowns, such as the 
cell migration that will occur on the scaffold region, we propose to use SPIO and 
cellular MRI.  These include the migration of cells within and outside of a scaffold 
region, as well as the potential migration of native cells into the scaffold from 
regions proximal to the site of the implant. The ability to observe the type of cells 
that would adhere/migrate longitudinally and preferentially in/out of the scaffold 
material is a key aspect in predicting the quality and quantity of tissue that would 
form. On the other hand, efforts to label and track PDLSCs, a potential cell 
source in heart valve tissue engineering has to date not been performed. 
3. OBJECTIVES  
Our objectives were to conduct an in-depth study of the longitudinal position and 
migration patterns of cells during the engineered heart valve tissue development 
process under static and dynamic environments. This would be achieved through 
SPIO cell labeling and subsequent tracking studies by MRI. In addition, we 
wanted to investigate the potential of PDLSCs as a single, feasible source for 
heart valve tissue engineering. These hypothesis are addressed by the following 
specific aims: 
3.1 Specific Aim 1: Acquire longitudinal MRI images of SPIO-labeled 
cell populations in engineered valve tissue in cell culture with maximum 
possible cell contrast without compromising cell viability, proliferation and 
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differentiative capacity – Specifically, we wish to augment iron oxide uptake in 
human vascular cells (native pulmonary artery smooth muscle  (SMCs), 
endothelial cells (ECs)) and label human periodontal ligament derived stem cells 
(PDLSCs) from currently used protocols without compromising cellular viability 
and without affecting cell phenotypes. 
3.2 Specific Aim 2: Differentiate PDLSC into concomitant EC and 
SMC through use of a growth factor cocktail, mechanical stimulation or 
both – PDLSCs would be differentiated into ECs and SMCs in cell culture with 
growth factors, and/or would be mechanically stimulated under steady flow using 
shear stress at 1 dyne/cm2 to promote further differentiation that is supportive of 
the heart valve phenotype. 
3.3 Specific Aim 3: Perform biological studies of the SPIO-labeled 
cells in 3D static or dynamic polymer seeded scaffolds determine 
extracellular matrix (ECM) production and changes in cell phenotype – Cell-
seeded polymers would be housed in a bioreactor and exposed to fluid induced 
shear stress conditioning. Vascular cell migratory activity under dynamic states 
would be compared to static controls by means of SPIO as the contrast agent. 
4. MATERIALS AND METHODS 
4.1 Aim 1 Methodologies 
 
Cell Labeling: Various concentrations of Bangs particles (Bangs 
laboratories, Fishers, IN), which are co-labeled with a fluorescent red tag 
(excitation=660nm, emission =690nm) were used to label the vascular cells 
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(Genlantis, Fisher Scientific, IN) at two different incubation times (24 hours and 
48 hours), while the PDLSCs (University of Miami, Tissue Engineering 
Laboratory, Miami, FL) were labeled at an incubation time period of 24 hours. 
After proliferating all cell lineages, roughly, 3 million cells and were re-plated 
equally into 15 chamber slides (Fisher Scientific, PA). Vascular cells (n=5) were 
labeled for a 24 hour period with three different concentrations of SPIO 
microparticles (0.23g of Fe per ml of solution: 50, 100 and 200 μg/ml). 
Concomitantly, during the same 24 hour period, cells were exposed to 4.5μg/ml 
of a transfection agent (Protamine Sulfate, Sigma, MO). A second group of the 
vascular cells were labeled with ferumoxides in the same manner except that the 
incubation time was doubled, i.e., 48 hours. On the contrary, the PDLSCs were 
labeled following the protocol used by Suzuki et al. (31) for embryonic stem cells. 
The PDLSCs (n=5) were labeled with SPIO microparticles at a concentration of 
200 μg/ml for 24 hours. During this 24-hour period, the PDLSC’s were also 
exposed to a 12μg/ml of the transfection agent (Protamine Sulfate, Sigma, MO). 
MR Imaging of Cells in Culture: For vascular cells (SMC and EC), MRI 
datasets were collected on a 4.7-Tesla (200MHz) 40-cm bore magnet with a 
Bruker Avance™ (Bruker Inc., Rheinstetten, Germany) console using an actively 
shielded gradient set.  A linear birdcage radio frequency (RF) coil with a diameter 
of 35mm was used for imaging the samples in order to increase sensitivity of 
signal detection.  A 2D gradient echo fast imaging (GEFI) pulse sequence with 
180mm resolution and 10ms time of echo (TE) was employed to visualize the 
labeled vascular cells in the chamber slide.  On the other hand, for PDLSC, MRI 
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datasets were collected on a 3.0-Tesla (123MHz) 60-cm bore magnet with a 
Magnetom Trio, (Tim, Simens) console using an actively shielded gradient set.  A 
transmit/receive 15 channel knee coil that provides high resolution.  A 3D 
gradient echo pulse sequence with 60mm resolution and 11.2ms TE and 100ms 
relaxation time (TR) was employed to visualize the labeled PDSLCs in the 
chamber slide.  
Proliferation and Viability: SPIO-labeled and unlabeled cells (EC, SMC 
and PDLSC) were cultured for 1 week to assess proliferation and viability. EC’s 
were cultured using Genlantis medium (Genlantis, San Diego, CA) while SMCs 
and PDLSC’s were grown in-vitro using Dulbecco’s Modified Eagle’s Medium  
(DMEM, Lonza, Basel, Switzerland) with 4.5 g/l glucose and l-glutamine 
(Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS, 
ATCC, Manasas, VA), and 1% penicillin/streptomycin (Invitrogen, Carlasbad, CA). 
At both the beginning and end of 1 week, live cells were manually counted using 
a hemocytometer. Dead cells were excluded by addition of Trypan Blue dye 
(Sigma Aldrich, St. Louis, MO) prior to the counting process.  
Iron Oxide Detection: After culturing SPIO-labeled and unlabeled cells 
(SMC, EC and PDLSC) for a week, they were rinsed with 0.01M Phosphate 
Buffered Saline (PBS) and detached from the T-75cm2 flask (Fisher Scientific, 
PA) by 0.25% Trypsin-EDTA (ATCC, Manasas, VA). Cell pellets were collected 
in a 15 ml conical tube (Fisher Scientific, PA) and transferred to chamber slides 
(n=6 per cell type). After the cells attached overnight, they were fixed with 10% 
formalin for further detection of iron oxide. Prussian Blue Stain: Slides (n=3 per 
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cell type) were then incubated in a 1:1 working solution of 2% Potassium 
Ferrocyanide and 2% Hydrochloride acid for 20 min at 55OC, washed in tap water 
followed by a counterstain of nuclear fast red for 5 min. The slides were then 
dehydrated through alcohol, and cleared in xylene. After mounting the slides with 
Permount (Fisher Scientific, PA) they were examined under an upright 
microscope for presence of iron particles inside the cells. Fluorescent red tag in 
Bangs Particles: Slides (n=3 per cell type) were counterstained for filamentous-
actin (F-actin, Invitrogen, Carlsbad, CA) using Alexa Fluor 488 conjugated 
phallotoxin at 5U/mL for 20 min at 26OC, and washed in PBS. The slides were 
then mounted and stained for DAPI with Vectashield Mounting Media (Invitrogen, 
Carlsbad, CA)) and examined under an inverted fluorescent microscope for 
presence of the red tag contained in the magnetic core of the Bangs particles 
(660 excitation, 690 emission).  
RNA Isolation and Reverse Transcription: The cells (SMC, EC and 
PDLSC) were rinsed with PBS and detached from the T-75cm2 flask (Fisher 
Scientific, PA) by 0.25% Trypsin-EDTA (ATCC, Manasas, VA). Cell pellets were 
collected in a 15 ml conical tube (Fisher Scientific, PA). The pellet was 
transferred to a 1.5 ml RNAase free tube to perform the RNA isolation procedure. 
Total mRNA was purified with SV Total RNA Isolation System (Promega, 
Madison, WI). 1µg of total mRNA was used for reverse transcription reaction with 
GoScript™ Reverse Transcription System (Promega, Madison, WI). The cDNA 
was synthesized using oligo (dT)15 primer, according to the manufacturer’s 
instructions.  
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qRT-PCR for SMC, EC and PDLSC Marker Genes: Quantitative RT-
PCR was performed using GoTaq® qPCR Master Mix (Promega, Madison, WI).  
Signals were detected with a Step One Real-Time PCR System (Applied 
Biosystems, Carlsbad, CA). The PCR tube contains 2 primers and SYBR® green 
I dye reagent along with the cDNA, a product of reverse transcription mentioned 
above. The primers were designed to amplify the target sequence. The PCR 
primer sequences for SMC, EC and PDLSC are listed in Table 1. The sample 
tube was held at 950C, 2 minutes before the cycle started to activate the Taq 
polymerase. The cycling parameters were 950C, 5 seconds; 600C, 45 seconds; 
950C, 15 seconds.  
Table 1: qRT-PCR Primer Sequences 
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4.2 Aim 2 Methodologies 
 
Cell Differentiation: After PDLSCs reached 100% confluency, they were 
separated into 4 groups during a week period at a cell density of 1*106 cells/cm2. 
Group [1] – Negative control: This group contained PDLSCs cultured in its basal 
media. Group [2] – Differentiating Media: This group contained PDLSCs exposed 
to a special media believed to induce SMCs and ECs differentiation. Group [3] – 
BioFlux: This group of PDLSCs was subjected to a physiologically relevant shear 
flow (1 dyne/cm2) while being cultured in the Bioflux200 system (Fluxion, San 
Francisco, CA). Group [4] – Differentiating Media + BioFlux: This group combined 
the special media and the physiological relevant shear flow (1 dyne/cm2) while 
culturing the PDLSC inside the Bioflux200 system (Fluxion, San Francisco, CA). 
As positive control, both human vascular EC and SMC were utilized. [1] Negative 
control: This group contained PDLSCs cultured in its basal media. [2] 
Differentiating Media: This group contained PDLSCs exposed to a special media 
believed to induce SMCs and ECs differentiation. [3] BioFlux: This group of 
PDLSCs was subjected to a physiologically relevant shear flow (1 dyne/cm2) 
while being cultured in the Bioflux200 system (Fluxion, San Francisco, CA). [4] 
Differentiating Media + BioFlux: This group combined the special media and the 
physiological relevant shear flow (1 dyne/cm2) while culturing the PDLSCs inside 
the Bioflux200 system (Fluxion, San Francisco, CA). As positive control, both 
human vascular EC and SMC were utilized. 
Differentiating Media:  The cocktail mix utilized to culture cells in groups 
[2] and [4] was hypothesized to induce differentiation of PDLSCs into EC and 
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SMC concomitantly as a similar version of the mix has already been effective in 
differentiating PDLSCs into cardiomyocytes (32). Therefore, since PDLSCs can 
be differentiated into other cardiovascular cell lineages, such as cardiomyocytes, 
it serves to argue that they have the potential to become vascular SMCs and/or 
ECs (33,34). The cocktail mix we have utilized contains DMEM High glucose 
(Invitrogen, Carlsbald, CA), 10% fetal bovine serum (ATCC, Manasas, VA), 1% 
Penicillin/streptomycin (ATCC, Manasas, VA), as well as 10ng/mL of vascular 
endothelial growth factor (VEGF, BD Science, USA), 25ng/mL of basic fibroblast 
growth factor (bFGF, Invitrogen, Carlsbald, CA), 10ng/mL of Insulin-like Growth 
Factor (IGF-1, Invitrogen, Carlsbald, CA), 10uM of 5-azacytidine (Sigma Aldrigh, 
St. Louis, MO), 100nM Ascorbic Acid (Sigma Aldrich, St. Louis, MO), 10nM 
Oxytocin (Sigma Aldrigh, St. Louis, MO),  10nM hydrogen peroxide (Sigma 
Aldrich, St. Louis, MO).  The cocktail mix was changed every two days during a 
1-week period, with exception of the hydrogen peroxide, which was added daily.  
BioFlux 200 System: This system enables the user to prepare 8 cell 
assays in parallel, while controlling their temperature. Its interface connects an 
electropneumatic pump to the well plates, which initiates the “controlled shear 
flow”.  BioFlux 200 can also be connected to an inverted regular or fluorescent 
microscope; allowing the user to for example, perform immunohistochemical 
findings while the cells are being stimulated. Therefore, this system is highly 
conducive for assessing stem cell differentiation outcomes. 
Cell Phenotype: After the 1-week period of culturing the cells under the 
differentiating media, cells from the four separate groups were subjected to PCR 
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and immunohistochemistry in order to check for SMC and EC cell phenotypes. 
RNA isolation, reverse transcription and qRT-PCR methods were performed in a 
similar manner to that of the labeled cells as described earlier for the SPIO-
labeling studies. 
Immunohistochemistry: Characterization of cell phenotype by 
immunohistochemistry was performed. After the 1-week culture period, cells from 
all groups were rinsed with PBS and detached from the T-75cm2 flasks (Fisher 
Scientific, PA) by Trypsin-EDTA (ATCC, Manasas, VA). Cell pellets were 
collected in a 15 ml conical tube (Fisher Scientific, PA) and transferred evenly to 
chamber slides (n=6 per group) at a density of 200,000 per chamber slide. After 
24 hours, the slides were fixed in 10% buffered formalin. Sections were then 
washed in PBS-T  3 x 5min. The sections were incubated for 1 hour in Normal 
Donkey Serum (1:10 in PBS-T). Next, the sections were incubated (Overnight, 
4°C) with mouse alpha-smooth muscle actin (1:500, Sigma Aldrich, St. Louis, 
MO) or rabbit von Willebrand Factor (vWF, 1:500, Invitrogen, Carlsbad, CA). 
After washing in PBS, the sections were incubated in their secondary antibodies 
for two hours Texas Red (1:800) anti-mouse IgG and Texas Red (1:400) anti-
rabbit IgG, to identify anti-alpha-sma or anti-vWF respectively. The sections were 
washed again with PBS 3x5min. Finally, the slides were mounted and stained for 
DAPI with Vectashield Mounting Media (Invitrogen, Carlsbad, CA)) and examined 
under an inverted fluorescent microscope.  
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4.3 Aim 3 Methodologies 
 
Cell Labeling: PDLSC’s were labeled with Bangs particles (Bangs 
laboratories, Fishers, IN), co-labeled with a fluorescent red tag 
(excitation=660nm, emission =690nm) at a concentration of 200ug/mL. SMCs 
and ECs were labeled in a similar manner as previously described. However, the 
Bangs particles utilized to label the SMCs were colabeled with a green tag 
(excitation=480, emission=520) while the ECs were labeled with the Bang’s 
particles colabeled with the red tag (excitation=660nm, emission =690nm) in 
order to distinguish the cell type under a fluorescent microscopy. 
Cell Seeding: A non-woven 50:50 blend of polyglycolic acid (PGA) and 
poly-L-lactic acid (PLLA) scaffold (Biofelt, Concordia Fiber, RI) was utilized for 
cell seeding. This scaffold has an approximate fiber diameter of 0.012-0.015mm 
and its density is 61.75 mg/ml. Its benefits include its high porosity factor (>97%).  
The PGA/PLLA scaffold has already been successful demonstrating its ability to 
rapidly grow cells and form an organized 3D tissue structure (1,5). Rectangular 
scaffold samples (n=12) of dimensions (17mm X 6mm X 1mm) were subjected to 
Ethylene Oxide gas sterilization (AN 306, Anprolene, Andersen Products 
Inc., Haw River, NC) for 12 hours. After the sterilization period, each sample was 
placed in a hybridization tube and seeded with previously SPIO labeled and 
unlabeled SMC (~87%) –EC (~13%) at a density of 2x106 million cells per cm2. 
The hybridization tubes (n=2) were then placed on a rotisserie (Fisher Scientific, 
PA) and rotated at 8rpm inside a standard cell culture incubator operating at 
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37OC and 5% CO2 for one day+ 7days (static culture). The SPIO-labeled and 
unlabeled PDLSC-plated scaffolds were seeded in the PGA/PLLA scaffold in a 
similar manner. 
Monitoring tissue development process: The mechanical conditioning 
for the seeded scaffolds was developed in a u-shaped bioreactor shown on 
Figure 1. This bioreactor is capable of replicating physiological hemodynamic 
conditions during in-vitro tissue development, which has been widely recognized 
to be an essential aspect of engineered heart valve tissue formation (5,16). Post-
static culturing of the scaffolds (n=12) during a total of 8 days in the rotisserie, 
they were separated into two groups: static and flow. Scaffolds (n=6) were then 
then cultured also for a two week period in dynamic conditions, housed in the u-
shaped bioreactor being exposed to a physiologically relevant continuous flow 
rate (750 mL/min) which develops a shear stress of a 5-6 dynes/cm2 (18). The 
tissue formation studies were based on the SMC-EC-seeded-scaffolds, as well 
as the PDLSC seeded scaffolds.  
Figure 1: The u-shaped bioreactor for in vitro mechanical conditioning. 
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MRI of PDLSC-seeded Scaffold Inside Bioreactor: MRI datasets were 
collected on a 3.0-Tesla (123MHz) 60-cm bore magnet with a Magnetom Trio, 
(Tim, Simens) console using an actively shielded gradient set.  A transmit/receive 
15 channel knee coil that provides high resolution.  A 3D gradient echo pulse 
sequence with 60mm resolution and 11.2ms TE and 100ms relaxation time (TR) 
was employed to visualize the labeled PDSLC-seeded scaffold inside the 
bioreactor.  
Histology: SPIO-labeled PDLSC-seeded scaffolds were fixed and 
embedded with paraffin at different time points for the samples exposed to flow 
or static conditions. While the samples cultured under static conditions were fixed 
and embedded in paraffin at: 1-week post static culture, 2-weeks post static 
culture and 3-weeks post static culture. Samples (n=2 at each time point/group) 
were washed in PBS, and fixed in 10% formalin, then embedded in paraffin and 
sectioned at 10um. Sections were stained with hematoxylin and eosin for overall 
morphology. 
Fluorescence Validation: In order to see the migratory activity of PDLSC 
in the PGA/PLLA copolymer; and to validate the presence of iron through the 
fluorescent tag of the Bang’s particles, sections were mounted and stained for 
DAPI with Vectashield Mounting Media (Invitrogen, Carlsbad, CA)) and examined 
under an inverted fluorescent microscope. 
DNA Quantification: DNA was quantified after the 3 week by a technique 
adapted from Ramaswamy et al. (35). For each assay, thin samples (8x7X1 mm) 
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were cut from PDLSC/SMC-EC seeded scaffolds (controls, and scaffolds 
exposed to flow) along their long axis and weighed prior to extraction. Each 
sample was then placed in a microcentrifuge tube and extracted in 1ml of 0.125 
mg/ml papain solution for 10 hours in a 60OC water bath. The 0.125mg/ml 
papain solution must made immediately prior to use by adding l-cysteine 
dihydrochloride (Sigma Aldrich, St. Louis, MO) to a phosphate buffered EDTA 
solution (PBE, Sigma Aldrich, St. Louis, MO) to a concentration of 10 mM, adding 
papain (minimum 10 units/mg (P4762); Sigma) to a concentration of 0.125mg/ml. 
The PBE solution was made beforehand by adding sodium phosphate dibasic 
(Sigma) and Ethylenediaminetetraacetic acid (EDTA; Sigma Aldrich, St. Louis, 
MO) to deionized water at concentrations of 100 and 10 mM, respectively. The 
PBE solution needs to be balanced to pH 6.5 with 0.5 N hydrochloric acid (Sigma 
Aldrich, St. Louis, MO) and sterile filtered using a vacuum filtration unit (0.2 mm 
PES membrane; Nalgene Labware). The extracts were then assayed using the 
PicoGreen dsDNA quantitation kit (Invitrogen, Carlsbad, CA) as per the 
manufacturer’s instructions and using a Genesys 20 spectrophotometer (Thermo 
Spectronic, Rochester, NY). 
Extracellular Matrix Quantification: Collagen and sulfated 
glycosaminoglycans (S-GAG) were assayed following a similar technique used 
by Ramaswamy et al. (35). For the collagen assay, thin samples (8x7X1 mm) 
were cut from PDLSC/SMC-EC seeded scaffolds (controls, and scaffolds 
exposed to flow) along their long axis and weighed prior to extraction. Total 
collagen was extracted from samples using a solution of 0.5M acetic acid (Sigma 
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Aldrich) and pepsin ((1 mg/ml), Sigma Aldrich, St. Louis, MO). Each sample was 
the placed in a microcentrifuge tube and incubated in 1ml of extraction solution 
on a rocker table ((Orbitron Rotator); Boekel Scientific, Feasterville, PA) at 4OC 
for 16 hours. For the S-GAG assay, the same extract used for the DNA assay 
was utilized. Subsequent to the extraction procedure, the collagen and S-GAG 
extracts were assayed following the protocols of the manufacturer’s provided by 
Sircol and Blyscan assay kits. (Biocolor Ltd. Newtownabbey, N. Ireland) using a 
Genesys 20 spectrophotometer (Thermo Spectronic, Rochester, NY). 
4.4 Statistical Analysis 
 
Statistical analysis was performed utilizing the SPSS Software Version 
16.0 for the independent t-test for all proliferation and viability tests (n=5), as well 
as gene expression tests (n=3) from Aim 1. For Aim 2, four different groups of 
cells were compared; in addition we used ANOVA through MATLAB 7.12 to be 
able to compare the three groups pairwise (1 to 2, 1 to 3, 1 to 4, etc), so the 
probability of   an incorrect result would be: 1 - (0.95 x 0.95 x 0.95)   =  14.3% in 
order to prevent type I and type II errors. Finally, SPSS Software Version 16.0 
was also utilized for performing statistical analysis for extracellular matrix and 
DNA quantification results (n=3, replicates=5) from Aim 3. 
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5. RESULTS AND DISCUSSION PART I: SPIO MICROPARTICLE 
LABELING STUDIES FOR THREE DIFFERENT CELL POPULATIONS, 
IMPLICATIONS FOR TISSUE ENGINEERED HEART VALVES  
 
MR Imaging of Cells in Culture: We determined that vascular cells 
exposed to a concentration of 200 μg/ml of SPIO microparticles and incubated 
for a period 48 hours was optimum for detection by MRI (Figure 2). Similarly, 
PDLSCs were successfully imaged when exposed to a SPIO concentration of 
200 μg/ml and incubated for a period of 24 hours (Figure 2e) (36,37). 
 
Figure 2: (A-B) A cMR image of the SMCs with a 200μg/mL concentration of the SPIO particles. (A) 
Under 24 hours incubation time. (B) Under 48 hours incubation time. (C-D) A cMR image of the ECs 
under a 24 hours incubation time. (C) With a 100μg/mL concentration of the SPIO particles. (D) With 
a 200μg/mL concentration of the SPIO particles.  (E) A cMR image of the PDLSCs with a 200μg/mL 
concentration of the SPIO particles under 24 hours incubation time. 
Proliferation and Viability: Figure 3 and Figure 4 below show the 
proliferation and viability for the vascular cells (SMCs and ECs) unlabeled, and 
labeled for the three SPIO concentrations previously described after a 48 hour 
incubation time. Figure 5 and Figure 6 show the proliferation and viability for the 
PDLSC unlabeled and labeled at 200ug/mL. No significant (N.S, p>0.05) values 
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were found between proliferation and viability between labeled and unlabeled 
cells (SMCs, ECs, and PDLSCs). Viability for SMCs unlabeled cells (UC) was 
89±3.5%, while for labeled cells (LC) it was75±3%. ECs, viability of UC was 
89.8±2.7%, and LC was 87±2%. As for PDLSC (UC) was 96±1.3%, while for 
labeled cells (LC) it was 94±1%. Proliferation of all cell types was doubled 
measured over one week, and values were not significantly different (p>0.05) 
between LCs and UCs. 
 
Figure 3: Proliferation of human vascular cells SMC (green) and EC (red) unlabeled, and  SPIO-
labeled at three different concentrations: 50, 100 and 200 ug/m in a 48 hour incubation time. The 
values for both cell types at the different cell concentration did not have any significant differences 
(N.S) based on the independent t-test (n=5). 
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Figure 4: Viability of human vascular cells SMC (green) and EC (red) unlabeled, and  SPIO-labeled at 
three different concentrations: 50, 100 and 200 ug/m in a 48 hour incubation time. The values for 
both cell types at the different cell concentration did not have any significant differences (N.S) based 
on the independent t-test (n=5). 
 
 
Figure 5: Proliferation for PDLSC’s unlabeled and SPIO-labeled at a concentration of 200 ug/ml. 
There were no statistical  differences in the values based on the independent t-test (n=5). 
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Figure 6: Viability for PDLSCs unlabeled and SPIO-labeled at a concentration of 200 ug/ml. There 
were no statistical differences in the values based on the independent t-test (n=5). 
Iron Oxide Detection: The Prussian blue stain was positive for iron oxide 
particles inside the cells for the three cell lineages (Figure 7). On the other hand, 
positive red staining indirectly confirmed intracellular iron oxide uptake as shown 
in Figure 8 , Figure 9 and Figure 10.  
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Figure 7: Prussian Blue Stain taken at 100X. Scale bar=200μm. Blue dots represent the iron, while 
the cytoplasm is shown in a light pink color. (A) SMCs, (B) ECs and (C) PDLSCs cell populations. 
 
 
 
Figure 8: Immunofluorescence of SMCs taken at 100X, Scale bar=200μm (Left) and 200X, Scale 
bar=100μm(Right). Both images were stained for F-actin (green), DAPI (blue) and the fluorescence 
from the Bangs particles (red). 
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Figure 9: Immunofluorescence of ECs taken at 100X, Scale bar=200μm (Left) and 400X, Scale 
bar=100μm(Right). Both images were stained for F-actin (green), DAPI (blue) and the fluorescence 
from the Bangs particles (red). 
 
 
 
Figure 10: Immunofluorescence of PDLSCs taken at 100X, Scale bar=200μm (Left) and 200X, Scale 
bar=50μm(Right). Both images were stained for F-actin (green), DAPI (blue) and the fluorescence 
from the Bangs particles (red). 
 
qRT-PCR for SMC, EC and PDLSC Marker Genes: The change in cycle 
threshold (∆Ct) values were averaged and normalized with GAPDH using the 
∆∆Ct method (38). Fold changes were calculated as 2-∆Ct and the gene 
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expression ratio of each of the three types of cells (SMCs, ECs and PDLSCs) 
unlabeled relative to labeled indicated as shown on Figure 11, Figure 12 and 
Figure 13. Specifically, for SMCs GAPDH, B-1 integrin and Thy-1 were both 
expressed with no significant differences in UC and LC. For ECs, GAPDH, Flk-1, 
and VE-Cadherin were all expressed with no significant differences; while 
PECAM-1 was greatly expressed in LC compared to UC, and Tie-1 was 
expressed greatly in UC compared to LC. Lastly, for PDLSCs, GAPDH, Klf4, and 
Nestin were all expressed with no significant differences in both UC and LC. Also,  
Slug was expressed greatly in UC compared to LC. 
 
Figure 11: Quantitative RT-PCR of SMC unlabeled (2) and labeled with SPIO microparticles (2). Each 
column is normalized by GAPDH (endogenous gene). Values for all genes were not statistically 
different (n=3). 
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Figure 12: Quantitative RT-PCR of EC unlabeled (5) and labeled with SPIO microparticles (5). Each 
column is normalized by GAPDH. Values for all genes were not statistically different with exception 
of PECAM 1 and Tie 1 (P < 0.05) (n=3). 
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Figure 13: Quantitative RT-PCR of PDLSC unlabeled (5) and labeled with SPIO microparticles (5). 
Each column is normalized by GAPDH. Values for all genes were not statistically different with 
exception of Sox 2 and Slug (P < 0.05) (n=3). 
Treatments for congenital heart valve disease clearly need advanced 
procedures for examining the effectiveness of the treatment during in vivo 
conditions. MRI can be utilized in cellular processes to longitudinally track the 
fate of cells seeded on a specific scaffold. Noninvasive longitudinal monitoring by 
means of MRI is increasingly being utilized on processes related to cell and 
tissue engineering. These developments can drastically aid in the evaluation of 
tissue-engineered constructs (39,40). SPIO nanoparticles have been 
demonstrated to work in MRI investigations without harming the cell in any way 
(24-28). Terrovitis et al. showed that labeling BMSC’s with ferumoxides was not 
toxic to the cells, and they could even be further visualized in collagen 
gels/scaffolds (26). In another study performed by Ko et al (29) cellular MRI 
N.S 
N.S 
N.S 
P < 0.05 
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methodologies were demonstrated to allow for visualization of an implanted 
scaffold as well as the cellular behavior around the scaffold in a mouse model. 
He utilized SPIO-labeled-hMSCs, which were then cultured in a scaffold: gelatin 
sponge to support cell growth and proliferation (29). In a similar manner, MRI has 
been reported to be useful in monitoring tissue engineering heart valve (TEPV) 
growth and function in-vivo by Hill et al (22). As mentioned earlier, MRI allows 
cell detection by accelerated T2* decay, which are represented as hypointense 
regions caused by the intracellular iron oxide particles (41). This visualization is 
necessary from the beginning of the in-vitro culturing period of the engineered 
construct and could in theory be progressively tracked, even after implantation 
(41).  Harrington et al (42) utilized cellular MRI to track the fate of SPIO labeled 
macrophages seeded onto functional tissue engineered vascular grafts (TEVGs) 
through serial imaging. In their study, seeded cells were rapidly lost from 
implanted scaffolds instead of progressing into cells in the neovessel as 
hypothesized by their group. However, their findings were a successful 
application of noninvasive MRI for a serial study of cellular level processes in 
tissue engineering (42).  
In this study, the three cell lineages (SMCs, ECs and PDLSCs) proliferate 
and were viable after being labeled with SPIO microparticles at 200 μg/mL They 
were successfully visualized using T2* contrast by MRI 1 week post-labeling. 
MRI slices were co validated by Prussian blue staining and fluorescence 
microscopy confirmed the presence of the ferumoxide particles as evidenced by 
the detection of the co-labeled red tag of the Bang’s particles intracellularly. The 
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migratory activity of the cells could also be tracked longitudinally during their 
developmental process, which would permit us to understand their in vivo 
hemodynamic environment in future work. 
6. RESULTS AND DISCUSSION PART II: PDLSC AS A POTENTIAL 
CELL SOURCE FOR HEART VALVE TISSUE ENGINEERING  
 Cell Phenotype: The ∆Ct values were averaged and normalized with 
GAPDH using the ∆∆Ct method (38). Fold changes were calculated as 2-∆Ct and 
the gene expression ratio of each of the four groups (negative control, 
differentiating media, BioFlux, and differentiating media + BioFlux) indicated as 
shown on Figure 14. ANOVA test was performed to compare the four groups 
pairwise (Table 2 through 7). Table 8 summarizes the gene expression 
comparison among all groups. Table 9 on the other hand shows the percentage 
increase of gene expression of all groups compared to group 1. There was an 
increased percentage of group 4 over groups 2 and 3 in genes Thy-1, Pecam-1 
and Flk-1 and Ve-Cadherin. 
Based on results from qRT-PCR on Figure 14, P-values from Tables (2 
through 7) as well as gene expression comparison (Table 8) and percentage 
increase comparison (Table 9) it was determined that the highest gene presence 
for both smooth muscle cells and endothelial cells was produced from RNA 
extracted from group 4, i.e., PDLSCs exposed to our differentiating media and 
flow in the BioFlux system (1dyne/cm2). There was a significant affect (P < 0.05) 
of these two variables for the cells to positively express genes for both smooth 
muscle  (beta-1 integrin and Thy 1) and endothelial (Pecam-1, Flk-1, VE-
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Cadherin) cell phenotypes compared to all other groups. There were also 
significant differences (P < 0.05) in the expression of all genes when comparing 
them against each other as seen on Tables 2 through 8. However, these results 
also showed a considerable effect in the differentiative capacity of PDLSCs 
based on just flow  (group 3) or differentiation medium (group 2) as both of these 
groups developed gene expression in the qRT-PCR results. The effect of 
differentiation medium alone on PDLSCs was significant (P < 0.05) for EC gene 
expression over basal medium; however, it was not for SMC gene expression 
(Tables 2 through 7). Similarly, the effect of flow alone on PDLSCs compared to 
basal medium without flow was significantly different (P < 0.05) for both SMC and 
EC phenotypes. Therefore flow alone had a higher effect on the differentiative 
capacity of PDLSCs than the differentiative medium. Our control group (group 1) 
of cells that were cultured under their regular basal medium did not show 
significant expression of either SMC or EC phenotypes.  
 
 34
 
Figure 14: Quantitative RT-PCR of PDLSC (n=3). Group 1: Cells cultured in regular basal medium. 
Group 2: Cells cultured in differentiating media. Group 3: Cell cultured in basal medium and exposed 
to 1 dyne/cm2. Group 4: Cells cultured in differentiating media and exposed to 1 dyne/cm2. Each 
column is normalized by GAPDH. 
 
Table 2: P-value for GAPDH gene expression within the four groups. 
GAPDH 
Sum of 
Squares 
(SS) 
Degrees of 
Freedom 
(df)  
Mean of 
Squares 
(MS) F-Test P-Value 
Groups 0.78 3 0.26 6.97 0.0127 
Error 0.30 8 0.04     
Total 1.08 11       
 
 
Table 3: P-value for Beta-1-Integrin gene expression within the four groups. 
Beta-1-
Integrin SS df MS F-Test P-Value 
Groups 79.35 3 26.45 47.2 1.97 x10^5 
Error 4.48 8 0.56     
Total 83.83 11       
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Table 4: P-value for THY-1 gene expression within the four groups. 
THY-1 SS df MS F-Test P-Value 
Groups 45.84 3 15.28 17.99 0.0006 
Error 6.79 8 0.85     
Total 52.63 11       
 
Table 5: P-value for PECAM-1 gene expression within the four groups. 
PECAM-1 SS df MS F-Test P-Value 
Groups 162.39 3 54.13 277.59 2.01x10^8 
Error 1.56 8 0.20     
Total 163.95 11       
 
Table 6: P-value for FLK-1 gene expression within the four groups. 
FLK-1 SS df MS F-Test P-Value 
Groups 156.67 3 52.22 124.58 4.71x10^7 
Error 3.35 8 0.42     
Total 160.02 11       
 
Table 7: P-value for VE-CADHERIN gene expression within the four groups. 
VE-
CADHERIN SS df MS F-Test P-Value 
Groups 119.20 3 39.73 26.8 0.0002 
Error 11.86 8 1.48     
Total 131.06 11       
 
Table 8: Gene expression comparison among all groups 
Groups being compared Genes significantly different from Group 4 (p<0.05)
Group 1 vs. Group 4 B-1-integrin, Thy 1, Pecam-1, Flk-1, Ve-cadherin 
Group 2 vs. Group 4 B-1-integrin, Thy 1, Pecam-1, Flk-1
Group 3 vs. Group 4 Ve-Cadherin
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Table 9: Percentage Increase of Gene Expression per Group Compared to Group 1 
 GROUP 2 VS. GROUP 1 GROUP 3 VS. GROUP 1 GROUP 4 VS. GROUP 1
BETA-I-
INTEGRIN 
59.43% 98.92% 98.93% 
THY-1 -251.80% 92.06% 95.15% 
PECAM-1 92.07% 99.72% 99.87% 
FLK-1 99.25% 97.86% 99.887% 
VE-CADHERIN 99.53% 97.86% 99.51% 
 
Immunohistochemistry: PDLSCs from group 1 (negative control) did not 
stain positive for either alpha-sma or vWF (Figure 15 (A and B)). While PDLSCs 
from group 2 showed positive staining for both gene markers (Figure 15C, 15D). 
In a similar manner, PDLSCs from groups 3 and 4 stained positively for both 
smooth muscle (alpha-sma) and endothelial cell markers (vWF) (Figure 16 (A 
and B); and Figure (16 and D)). Positive staining was confirmed with positive 
controls, i.e. smooth muscle cells and endothelial cells (Figure 17 (A and B)). 
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Figure 15: (A and B) represents staining for alpha-sma for cells from group 1: negative staining (A) 
and group 2: positive staining (B), while Figure 9(C and D) represents staining for vWF for cells from 
group 1: negative staining (A) and group 2: positive staining (B). DAPI (Blue) marks the nucleus of 
the cells, while Texas Red (Red) marks either alpha-sma (A and C) or vWF (B and D). The images 
were taken at 20X, on an upright fluorescent microscope.  
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Figure 16: (A and C) represents positive staining for alpha-sma for cells from group 3 (A) and group 
4 (B), while Figure 10(B and D) represents positive staining for vWF for cells from group 3 (A) and 
group 4 (B). Texas Red (Red) marks either alpha-sma (A and C) or vWF (B and D). The images were 
taken at 20X, on an inverted fluorescent microscope.  
  
Figure 17: (A) represents positive staining to alpha-sma for mooth muscle cells, while (B) represents 
positive staining for vWF for endothelial cells. DAPI (Blue) marks the nucleus of the cells, while 
Texas Red (Red) marks either alpha-sma (A ) or vWF (B). The images were taken at 20X, on an 
upright fluorescent microscope. 
alpha-sma vWF 
 39
 
Over the past decade, the potential of BMSCs to provide regenerative 
treatment strategies in cardiac disease have been investigated (1,5-9). 
Researchers have found that MSCs differentiate in vitro into cardiomyocytes and 
smooth muscle cells, however, there has not yet been clear evidence of MSCs 
differentiation to endothelial lineages under solely biomechanical environments 
(8, 43, 44). Embryonic stem cells (ESCs), on the other hand have been shown to 
have a high potency to develop cardiac phenotypes including both SMCs and 
ECs (13,14). In our study we utilized PDLSCs because subpopulations of this cell 
lineage have shown to express ESCs markers (Oct4, Sox2, Nanog, and Klf4), 
therefore exhibiting a higher differential potential than MSCs (12). Owing to their 
more primitive state, PDLSCs offer the possibility to differentiate into neurogenic 
(ectoderm), as well cardiomyogenic, osteogenic and chondrogenic (mesoderm) 
cell lineages suggesting extensive pluripotency capacities. To date, the only 
pluripotent stem cells with capacity to differentiate into the three germal layers 
(ectoderm, mesoderm and endoderm) are ESCs, however, based on recent 
findings by Huang et al (12) PDLSCs may provide similar pluripotency and 
perhaps the only cell type that can be derived from adults.  In addition, PDLSCs 
can easily be culture expanded and are potentially more immune-tolerant 
compared to BMSCs, and therefore could be used in an allogenic manner.  
These properties make PDLSCs an especially attractive cell source for 
cardiovascular tissue engineering therapeutics for use in applications such as 
severe congenital heart valve disease and anomalies. 
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             After examining phenotypic changes in the PDLSCs from all four groups 
using immunohistochemistry and RT-PCR we found out that there is a significant 
effect of culturing the cells with our differentiating cocktail media containing and 
dynamic conditioning by means of flow (1 dyne/cm2). Also, the use of only 
cocktail media, or shear stress  (1 dyne/cm2) also has an effect in valve like 
expression. However, flow has a much more dominant effect in comparison to  
biochemical stimulants in differentiating PDLSCs into valve phenotypes. 
7. RESULTS AND DISCUSSION PART III: VASCULAR CELL 
MIGRATORY ACTIVITY UNDER DYNAMIC STATES COMPARED TO 
STATIC CONTROLS BY SPIO-LABELED CELLS 
To observe cell behavior in a scaffold environment under static and steady flow 
states, we scaled up our studies to 3-D culture, with a focus on cell detection, 
visualization and distribution using the PDLSCs. 
MR Imaging: SPIO-labeled PDLSCs seeded in the PGA/PLLA scaffold 
under rotisserie culture for 1 week and subsequently housed in our u-shaped 
bioreactor were successfully labeled under a concentration of 200 μg/ml (Figure 
18).  The MRI scan parameters for the resulting T2*-weighted images that were 
acquired were with 60mm resolution and 11.2ms TE and 100ms TR. 
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Figure 18: MRI of PDLSC-seeded scaffolds in situ within the U-shaped bioreactor.  The figure shows 
axial and sagittal slices from T2*-weighted images.  Dark spots within the scaffold region are cells, 
which are hypointense due signal attenuation caused by the intracellular SPIO micro-particles. 
 Histology: We report representative histology for the PDLSCs, which 
were fixed and embedded with paraffin at different time points, cut in a 
microtome at 10µm in the axial direction, and stained for hematoxilyn and eosin 
(H&E) for general morphology (Figure 19). More cells were observed when 
cultured under flow conditions; meaning flow allows more cells to remain viable. 
Also, changes in morphology under flow states suggest induced differentiation. 
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Figure 19: H&E staining for general tissue assessment and organization of PDLSCs 2 weeks of 
culturing (A): Cultured under flow conditions. (B): Cultured under static conditions. Magnification is 
20x. 
 
Fluorescent Validation for PDLSC seeded scaffold: Sections were also 
mounted and stained for DAPI with Vectashield Mounting Media (Invitrogen, 
Carlsbad, CA)) and examined under an inverted fluorescent microscope to 
further validate the MR image for presence of the red tag contained in the Bangs 
particles for further validation of the iron oxide presence inside the cells (Figure 
20).   
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Figure 20: Immunofluorescence of PDLSC seeded scaffold  (A-B) Cultured under static conditions 
(C-D) Cultured under flow conditions. Magnification is 20x.  DAPI (nucleus), and Red (Bangs 
Particles). 
 DNA Quantification for SMC-EC-seeded Scaffolds: Based on our 
seeding density of 2x106 cells/scaffold, and results from Engelmayr et al (1) 
suggesting a seeding efficiency of 90% when utilizing PGA/PLLA as the 
scaffolding material we assumed that an average of 180,000 cells/scaffold were 
retained. Assuming a DNA content of 7.6 pg/cell (45), there was an initial DNA 
content of 13.68ug/scaffold. After 3 weeks of incubation the DNA concentration 
decreased to 4360 ng/g wet weight (68.1%) in the static group from the initial 
DNA concentration. Whereas in the group exposed to dynamic flow it decreased 
to 12720 ng/g wet weight (7.0%) as shown in Figure 21. The difference between 
the static and flow group is significantly different (p<0.05) meaning less cells died 
when they were exposed to flow. 
200um 200um 
200um 200um 
A C 
B D 
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Figure 21: DNA content of SMC-EC seeded scaffolds after 3 weeks of incubation. Values presented 
are the mean of the measurements for 3 samples. Error bars indicate standard error. 
 
 Extra Cellular Matrix Quantification for SMC-EC-seeded Scaffolds: 
After the 3 week period, the collagen concentration was 436.8±15.04 ug/g wet 
weight in the group exposed to flow compared with 218.9±25.9 ug/g wet weight 
in the static group. There was a 99.5% increase in collagen in the group exposed 
to flow compared to the static group (p<0.05). On the other hand, the S-GAG 
concentration was 351.6±44.5 ug/g wet weight in the group exposed to flow, 
compared to 424.38±36.6 ug/g wet weight in the control group. This represents a 
17.1% decrease in the GAG production from the scaffolds exposed to flow in 
comparison to the static controls (Figure 22), which is not significantly different. 
P < 0.05 
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Figure 22: Composition content of SMC-EC seeded scaffolds after 3 weeks of incubation. Values 
presented are the mean of the measurements for 3 samples. Error bars indicate standard error. 
Insignificant comparisons are designated by ‘‘N.S.’’. The group exposed to flow exhibited a 99.5% 
increase in collagen compared to the static group (p <0.05) (n=3) (r=5). 
DNA Quantification for PDLSC-seeded Scaffolds: DNA was quantified 
in the same way as for the SMC-EC-seeded scaffolds. Similarly, a seeding 
density of 2x106 cells/scaffold was utilized, and 90% cell retention was assumed. 
Therefore based on the 7.6 pg DNA content/cell (45), there was an average initial 
DNA content of 13.68ug/scaffold. 3 weeks post culture of the scaffold, the DNA 
concentration decreased to 4130 ng/g (69.8%)wet weight in the static group and 
decreased 8830 ng/g wet weight (35.5%) in the group exposed to dynamic flow 
as shown on Figure 23. The difference between the static and flow group is 
significantly different (p<0.05) meaning less cells died when they were exposed 
to flow. 
N.S P < 0.05 
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Figure 23: DNA content of PDLSC seeded scaffolds after 3 weeks of incubation. Values presented 
are the mean of the measurements for 3 samples. Error bars indicate standard error. (n=3) (r=5). 
Extra Cellular Matrix Quantification for PDLSC-seeded Scaffolds: 
After the 3 week period, for the PDLSC-seeded scaffolds the collagen 
concentration was 400.2±13.2 ug/g wet weight in the group exposed to flow 
compared with 207.8±10.2 ug/g wet weight in the static group. There was a 
93.3% increase in collagen group exposed to flow compared to the static group 
(p<0.05). Furthermore, the S-GAG concentration was 296.0±15.6 ug/g wet 
weight in the group exposed to flow, compared to 307.5±15.6 ug/g wet weight in 
the control group. This represents a 3.7% decrease in the GAG production from 
the scaffolds exposed to flow in comparison to the static controls, which is not 
significantly different (Figure 24). 
P < 0.05 
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Figure 24: Composition content of PDLSC seeded scaffolds after 3 weeks of incubation. Values 
presented are the mean of the measurements for 3 samples. Error bars indicate standard error. 
Insignificant comparisons are designated by ‘‘N.S.’’. The group exposed to flow exhibited a 93.3% 
increase in collagen compared to the static group (p <0.05). (n=3)(r=5) 
 
Mechanical conditioning is believed to stimulate tissue formation in 
engineered tissues. It has been shown by researchers (9,18-21) that mechanical 
properties of engineered heart valves can be improved through bioreactor-based 
mechanical stimulation. The u-shaped bioreactor utilized in our study has the 
potential to provide physiological hemodynamic conditions during in vitro tissue 
development while keeping laminar conditions as shown by precise steady state 
states which is an essential aspect for tissue formation. The effects of fluid shear 
stress on tissue formation can then be evaluated by bulk protein, differentiation 
capacity, mechanical properties and cell signaling events.  
We were able to successfully image a 3D construct with ferumoxide-
labeled PDLSCs under MRI, and further validate the presence of iron oxide 
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indirectly via fluorescent microscopy. At the same time we showed the general 
distribution of the PDLSCs that were seeded onto a 50:50 PLLA/PGA blend of 
biodegradable scaffolds through H&E staining. Thus, cell visualization on 3-D 
scaffolds specimens could be successfully carried out in situ in the U-shaped 
bioreactor, intermittently, during the steady flow-conditioning period.  These 
findings demonstrate the ability to successfully conduct cell tracking studies on 
scaffolds that are undergoing a mechanical conditioning process in a longitudinal 
fashion, using MRI. 
An intrinsic goal of TEPV efforts is to recapitulate native valve extra 
cellular matrix protein concentrations, namely, collagen, GAG and elastin. In our 
study we found that mechanical stimulation by means of a physiological relevant 
flow (750 mL/min) augmented the collagen production in both EC-SMC and 
PDLSC seeded scaffolds after 3 weeks of culture (1 week static + 2 week 
dynamic). SMC-EC seeded scaffolds were subjected to dynamic flow exhibiting 
increased collagen mass production levels compared to our static controls. 
Similarly, PDLSC seeded scaffolds exposed to dynamic flow also displayed 
higher collagen formation than non-flow cultured scaffolds. This represents a 
similar behavior in tissue formation by both SMC-EC and PDLSC seeded 
scaffolds. Also, consistent with other researchers (1,5), we found a reduction in 
the GAG concentration when applying dynamic flow to the cell-seeded scaffolds. 
Flanagan et al and Balguid et al (46,47) performed some studies on GAG 
production, finding that the integration of a GAG constituent to the scaffold 
causes enhanced extracellular matrix production.   The accelerated collagen 
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formation rates in the flow-groups may limit the cells ability to synthesize large 
concentrations of GAGs simultaneously.  GAG concentrations in the TEPV 
constructs reflective of native valves may be reached by exogenous 
supplementation; alternatively, some level of initial static tissue culture may be 
necessary before initiating the dynamic conditioning protocols.  In addition we did 
not examine elastin levels in our experiments.  Thus, further investigations are 
needed in order to further optimize the tissue engineering protocol. 
DNA content of both SMC-EC and PDLSC scaffolds was decreased after 
3 weeks of culture on both static and dynamic groups. This would mean that less 
cells are retained in the tissue over time, however the ability of the cells to 
secrete more collagen increases with physiological flow conditioning.  
For future studies, we would like to incorporate the flex and stretch 
features of the u shaped bioreactor, and see how cyclic flexure affects tissue 
formation over a 3 week period.  
8. CONCLUSION  
In summary, we were able to detect spatial position of cells noninvasively 
using MRI.  The cells (SMCs, ECs and PDLSCs) were efficiently labeled with 
SPIO microparticles at an optimum concentration of 200µg/mL in combination 
with of transfection agents, protamine sulfate at a concentration of 4.5µg/mL for 
vascular cells and 12µg/mL for stem cells. The iron oxide presence inside the 
cells was confirmed   by fluorescence microscopy (red tag). We expect that the 
 50
cellular MRI techniques performed for the cell populations in this study will guide 
protocol optimization during in vitro to in vivo translation of TEPV constructs.  
 On a separate note, we found that PDLSCs subjected to differentiating 
media, and a shear stress of 1 dyne/cm2 induces differentiation to SMC and EC 
phenotypes. PDLSCs have the potential to become a single cell source feasible 
for the creation of tissue engineering pulmonary valves as they have the ability to 
support valve cell phenotypes (e.g. SMC s and ECs).  They can be easily culture 
expanded and possess sufficient plasticity to remodel into valve tissue thus 
making them an appealing cell source for heart valve tissue engineering.  
We studied the effects of mechanical stimulation by means of steady flow, 
by the use of our u-shaped bioreactor, in which we placed seeded SMC-EC and 
PDLSC seeded scaffolds and effectively obtained more robust collagen matrix 
production. Therefore, the study shows that both native cells (SMC-EC) and our 
viable cell source (PDLSC) both augmented levels of collagen production when 
stimulated by physiological levels of flow. Cellular scaffolds were also 
successfully visualized in situ in the u-shaped bioreactor and successfully 
validated by means of histology and fluorescence microscopy. 
Significance: This project has an overall impact in the field of TEPVs. 
Specifically, it leads to a better understanding of the cell distribution of vascular 
cells and stem cells under static as well as steady flow states.   Fluid shear 
stresses are one of the major physical stimulatory components of native heart 
valve and thus from a biomimetic viewpoint is relevant to heart valve tissue 
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engineering studies. Also, we introduced PDLSC into the heart valve tissue 
engineering field; they were presented as a potential allogenic cell source for 
creating heart valve constructs by demonstrating concomitant differentiation into 
EC and SMC phenotypes. In particular, more complete EC differentiation was 
observed under combined biochemical and flow states. VE-CADHERIN was 
uniquely expressed under these conditions, which is indispensable for proper 
vascular development. 
Future Work: We hope that future in vitro studies will include longitudinal 
MR imaging of SPIO-labeled cells (SMC-EC and PDLSC) seeded on PGA/PLLA 
to be able to understand further the migration of cells when exposed to flow 
conditions in the u-shaped bioreactor. These studies can be then compared to 
the findings from this project related to tissue formation, differentiative capacity, 
plus histological and fluorescent validation of the iron oxide presence inside the 
cells. In addition, other stress states such as pulsatile flow, cyclic flexure and 
dynamic tensile stresses individually or in a coupled manner, need to be further 
investigated.  Nonetheless this work has taken the first steps in delineating the 
role of a fluid-induced stress state on cells relevant to engineered heart valve 
tissue engineering and forms the basis for further work that will examine the 
mechano-biology of evolving heart valve tissues. 
  
 52
REFERENCES 
1. Engelmayr Jr GC, Rabkin E, Sutherland FW, Schoen FJ, Mayer Jr JE, Sacks 
MS. The independent role of cyclic flexure in the early in vitro development of an 
engineered heart valve tissue. Biomaterials 2005;26(2):175–87. 
 
2. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding 
complications in patients with mechanical heart valve prostheses. Circulation 
1994;89:635– 41. 
 
3. Schoen, F. & Levy, R. 1999 Tissue heart valves: current challenges and future 
research perspectives. J. Biomed. Mater. Res. 47, 439–465. 
 
4. Mayer Jr. JE. Uses of homograft conduits for right ventricle to pulmonary 
artery connections in the neonatal period. Semin Thorac Cardiovasc Surg 
1995;7(3):130–2. 
 
5. Engelmayr Jr GC, Sales VL, Mayer Jr JE, Sacks MS. Cyclic flexure and 
laminar flow synergistically accelerate mesenchymal stem cell-mediated 
engineered tissue formation: implications for engineered heart valve tissues. 
Biomaterials 2006; 27(36):6083–95 
 
6. Schoen, F. J. 2005 Cardiac valves and valvular pathology: update on function, 
disease, repair, and replacement. Cardiovasc. Pathol. 14, 189–194. 
 
7. Schoen, F. J. 2006 New frontiers in the pathology and therapy of heart valve 
disease: 2006 Society for CardiovascularPathology. Distinguished Achievement  
Award Lecture, United States-Canadian Academy of Pathology, Atlanta, GA, 
February 12, 2006. Cardiovasc. Pathol. 15, 271–279. 
 
8. Sutherland FW, Perry TE, Yu Y, Sherwood MC, Rabkin E, Masuda Y, et al. 
From stem cells to viable autologous semilunar heart valve. Circulation 2005; 
111(21): 2783–91. 
 
9. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, Martin DP, et al. 
Functional 
living trileaflet heart valves grown in vitro. Circulation 2000;102(19 Suppl. 3): 
III44–9. 
 
10. Ramaswamy S, Schornack PA, Smelko AG, Boronyak SM, Ivanova J, Mayer 
JE, Sacks MS: SPIO Labeling Efficiency and Subsequent MRI Tracking of Native 
Cell Populations Pertinent to Pulmonary Heart Valve Tissue Engineering Studies. 
NMR in Biomedicine, (In press).  
11. Rabkin E, Schoen FJ. Cardiovascular tissue engineering. Cardi- ovasc 
Pathol 2002;11(6):305–17. 
 53
12. Huang CY, Pelaez D, Dominguez-Bendala J, Garcia-Godoy F, Cheung HS. 
Plasticity of stem cells derived from adult periodontal ligament. Regen Med. 2009 
Nov;4(6):809-21. 
13. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther 
MG, Kumar, RM, Murray HL, Jeener RG, Gifford DK, Melton DA, Jaenisch R, 
Young, RA. 
Core Transcriptional Regulatory Circuitry in Human Embryonic 
Stem Cells. Cell. 2005 September 23; 122(6): 947–956 
14. Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, Andrews 
PW, Beighton G, Bello PA, Benvenisty N, Berry LS, Bevan S, Blum B, Brooking 
J,Chen KG, Choo AB, Churchill GA, Corbel M, Damjanov I, Draper JS, Dvorak 
P, Emanuelsson K, Fleck RA, Ford A, Gertow K, Gertsenstein M, Gokhale 
PJ, Hamilton RS, Hampl A,Healy LE, Hovatta O, Hyllner J, Imreh MP, Itskovitz-
Eldor J, Jackson J, Johnson JL, Jones M, Kee K, King BL, Knowles BB, Lako 
M, Lebrin F, Mallon BS, Manning D, Mayshar Y,McKay RD, Michalska 
AE, Mikkola M, Mileikovsky M, Minger SL, Moore HD, Mummery CL, Nagy 
A, Nakatsuji N, O'Brien CM, Oh SK, Olsson C, Otonkoski T, Park KY, Passier 
R,Patel H, Patel M, Pedersen R, Pera MF, Piekarczyk MS, Pera RA, Reubinoff 
BE, Robins AJ, Rossant J, Rugg-Gunn P, Schulz TC, Semb H, Sherrer 
ES, Siemen H, Stacey GN,Stojkovic M, Suemori H, Szatkiewicz J, Turetsky 
T, Tuuri T, van den Brink S, Vintersten K, Vuoristo S, Ward D, Weaver 
TA, Young LA, Zhang W. Characterization of human embryonic stem cell lines by 
the International Stem Cell Initiative.  Nat Biotechnol. 2007 Jul;25(7):803-16. 
Epub 2007 Jun 17. 
15. Hutmacher DW, Goh JC, Teoh SH. An introduction to biodegradable 
materials for tissue engineering applications. Ann Acad Med Singapore 
2001;30(2):183–91.  
16. Hutmacher DW. Scaffold design and fabrication technologies for engineering 
tissues—state of the art and future perspectives. J Biomater Sci Polym Ed 
2001;12(1):107–24.  
17. Hoerstrup SP, Kadner A, Melnitchouk S, Trojan A, Eid K, Tracy J, et al. 
Tissue engineering of functional trileaflet heart valves from human marrow 
stromal cells. Circulation 2002;106(12 Suppl. 1):I143–50. 
 
18. Engelmayr Jr GC, Sacks MS. Prediction of extracellular matrix stiffness in 
engineered heart valve tissues based on nonwoven scaffolds. Biomech Model 
Mechanobiol 2008;7(4):309–21. 
19. Hoerstrup SP, Sodian R, Sperling JS, Vacanti JP, Mayer Jr JE. New 
pulsatile bioreactor for in vitro formation of tissue engineered heart valves. Tissue 
Eng 2000;6(1):75–9. 
 
20. Stickler, P., et al. Cyclically stretching developing tissue in vivo enhances 
 54
mechanical strength and organization of vascular grafts. Acta Biomaterialia, 
2010: 6(7), 2448-2456.  
 
21. Ramaswamy S, Boronyak S, Schmidt D, Sacks MS:Design and Evaluation 
of a New Flow-Stretch-Flexure Bioreactor for Mechanical Conditioning of 
Engineered Heart Valve Tissues in the Physiological Range. The TERMIS-NA 
2008 Annual Conference & Exposition, San Diego, CA, December 7 - 10, 2008. 
 
22. Hill JM, Dick AJ, Raman VK, Thompson RB, Yu ZX, Hinds KA, Pessanha BS, 
Guttman MA, Varney TR, Martin BJ, Dunbar CE, McVeigh ER, Lederman RJ. 
Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. 
Circulation 2003;108(8):1009-1014. 
23. Gottlieb D, Kunal T, Emani S, Aikawa E, Brown DW, Powell AJ, Nedder A, 
Engelmayr GC, Jr., Melero-Martin JM, Sacks MS, Mayer JE, Jr. In vivo 
monitoring of function of autologous engineered pulmonary valve. J Thorac 
Cardiovasc Surg; 139(3):723-731. 
 
24. Sosnovik DE . Molecular Imaging in Cardiovascular Magnetic Resonance 
Imaging: Current Perspective and Future Potential Top Magn Reson Imaging. 
2008 February ; 19(1): 59–68 
 
25. Ramaswamy S, Greco JB, Uluer MC, Zhang Z, Fishbein KW, Spencer RG. 
Magnetic resonance imaging of chondrocytes labeled with superparamagnetic 
iron oxide nanoparticles in tissue-engineered cartilage. Tissue Eng Part A 
2009;15(12):3899-3910. 
26. Terrovitis JV, Bulte JW, Sarvananthan S, Crowe LA, Sarathchandra P, 
Batten P, Sachlos E, Chester AH, Czernuszka JT, Firmin DN, Taylor PM, Yacoub 
MH. Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells 
seeded on collagen scaffolds-relevance to tissue engineering. Tissue Eng 
2006;12(10):2765-2775 
27. Arbab AS, Yocum GT, Rad AM, Khakoo AY, Fellowes V, Read EJ, Frank JA. 
Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit 
function or differentiation capacity of hematopoietic or mesenchymal stem 
cells.NMR Biomed. 2005;18:383–389 
28. Arbab AS, Frank JA. Cellular MRI and its role in stem cell therapy. Regen 
Med 2008;3(2):199-215. 
29. Ko IK, Song HT, Cho EJ, Lee ES, Huh YM, Suh JS. In vivo MR imaging of 
tissue-engineered human mesenchymal stem cells transplanted to mouse: a 
preliminary study. Annals of biomedical engineering 2007;35(1):101-108. 
30. Frangioni JV, Hajjar RJ. In vivo tracking of stem cells for clinical trials in 
cardiovascular disease. Circulation 2004;110(21):3378-3383 
 55
31. Suzuki Y, Zhang S, Kundu P, Yeung AC, Robbins RC, Yang PC. In Vitro 
Comparison of the Biological Effects of Three Transfection Methods for 
Magnetically Labeling Mouse Embryonic Stem Cells With Ferumoxides. Magnetic 
Resonance in Medicine 57:1173–1179 (2007) 
 
32. Pelaez, D. Role of Mechanical Strain on the Cardiomyogenic Differentation of 
Periodontal Ligament Derived Stem Cells”. A Dissertation at the University of 
Miami. May 2011 
33. Wang T, Xu Z, Jiang W, Ma A. Cell-to-cell contact induces mesenchymal 
stem cell to differentiate into cardiomyocyte and smooth muscle cell. Int J Cardiol. 
2006 Apr 28;109(1):74-81 
34. Li X, Yu X, Lin Q, Deng C, Shan Z, Yang M, Lin S. Bone marrow 
mesenchymal stem cells differentiate into functional cardiac phenotypes by 
cardiac microenvironment. J Mol Cell Cardiol. 2007 Feb;42(2):295-303. 
35. Ramaswamy S, Gottlieb D, Engelmayr GC Jr, Aikawa E, Schmidt 
DE, Gaitan-Leon DM, Sales VL, Mayer JE Jr, Sacks MS. The role of organ level 
conditioning on the promotion of engineered heart valve tissue development in-
vitro using mesenchymal stem cells.Biomaterials 31 (2010) 1114–1125 
36. Martinez C, Padgett K, Henao A, Ramaswamy S. Migration of Vascular Cells 
Exposed to Valve-Like Deformations: Implications for Heart Valve Tissue 
Engineering. TERMIS Conference Meeting, Orlando, FL, December 2010. 
37. Martinez C, Padgett K, Henao A, Pelaez D, Ramaswamy S. Iron Oxide 
Labeling of Three Different Cell Populations: Relevant to Tissue Engineered 
Heart Valves. BMES Conference Meeting, Hartford,CN, October 2011. 
38. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, 
Speleman F. Accurate normalization of real-time quantitative RT-PCR data by 
geometric averaging of multiple internal control genes. Genome Biol. 2002 Jun 
18;3(7):RESEARCH0034. 
39. Cahill KS, Gaidosh G, Huard J, et al. Noninvasive Monitoring and Tracking 
of Muscle Stem Cell Transplants. Transplantation 2004;78:1626–33. 
 
40. Rogers WJ, Meyer CH, Kramer CM. Technology insight: in vivo cell tracking 
by use of MRI. Nat Clin Pract Cardiovasc Med 2006; 3: 554–62. 
 
41. Zhang N, Mascheri N, Dharmakumar R, Li D. Cellular Magnetic Resonance 
Imaging: Potential for Use in Assessing Aspects of Cardiovascular Disease. 
Cytotherapy. 2008 ; 10(6): 575–586. 
 
42. Harrington JK, Chahboune H, Criscione JM, Li AY, Hibino N, Yi T, Villalona 
GA, Kobsa S, Meijas D, Duncan DR, Devine L, Papademetri X, Shin'oka T, 
 56
Fahmy TM, Breuer CK. Determining the fate of seeded cells in venous tissue-
engineered vascular grafts using serial MRI. FASEB J. 2011 Aug 16. 
 
43. Zhang G et al. A PEGylated Fibrin Patch for Mesenchymal Stem Cell 
Delivery. Tissue Eng 2006;12(1):9–19. 
44. Zhang G et al . Vascular differentiation of bone marrow stem cells is directed 
by a tunable three-dimensional matrix Acta Biomaterialia 6 (2010) 3395–3403 
 
45. Kim BS, Putnam AJ, Kulik TJ, Mooney DJ. Optimizing seeding and culture 
methods to engineer smooth muscle tissue on biodegradable polymer matrices. 
Biotechnol Bioeng 1998;57(1): 46–54. 
46. Flanagan TC, Wilkins B, Black A, Jockenhoevel S, Smith TJ, Pandit AS. A 
collagen-glycosaminoglycan co-culture model for heart valve tissue engi- neering 
applications. Biomaterials 2006;27(10):2233–46.  
47.Balguid A, Mol A, van Vlimmeren MA, Baaijens FP, Bouten CV. Hypoxia 
induces near-native mechanical properties in engineered heart valve tissue. 
Circula- tion 2009;119(2):290–7.  
 
